|
|
||||||||
Departments of Plant Sciences and
* Biochemistry, George S. Wise Faculty of Life Sciences, Tel-Aviv University, Ramat-Aviv 69978, Tel-Aviv, Israel
1Correspondence: Department of Plant Sciences at the Faculty of Life Sciences, Tel-Aviv University, Britania Bldg., Rm. 506, Ramat-Aviv 69978, Tel-Aviv, Israel. E-mail: mamgur{at}post.tau.ac.il
ABSTRACT
The structure of bioactive surfaces of proteins is a subject of intensive research, yet the mechanisms by which such surfaces have evolved are largely unknown. Polypeptide toxins produced by venomous animals such as sea anemones, cone snails, scorpions, and snakes show multiple routes for active site diversification, each maintaining a typical conserved scaffold. Comparative analysis of an array of genetically related scorpion polypeptide toxins that modulate sodium channels in neuronal membranes suggests a unique route of toxic site diversification. This premise is based on recent identification of bioactive surfaces of toxin representative of three distinct pharmacological groups and a comparison of their 3-dimensional structures. Despite their similar scaffold, the bioactive surfaces of the various toxins vary considerably, but always coincide with the molecular exterior onto which the C-tail is anchored. Superposition of the toxin structures indicates that the C-tails diverge from a common structural start point, which suggests that the pharmacological versatility displayed by these toxins might have been achieved along evolution via structural reconfiguration of the C-tail, leading to reshaping of new bioactive surfaces.Gurevitz, M., Gordon, D., Ben-Natan, S., Turkov, M., Froy, O. Diversification of neurotoxins by C-tail wiggling: a scorpion recipe for survival.
Key Words: toxic polypeptides scorpion neurotoxin bioactive surface
DIVERSIFICATION OF BIOACTIVITY IN TOXIC POLYPEPTIDES
PHYSICAL LIMITATION of various groups of animals
such as sea anemones (Coelenterata), cone snails (Mollusca), scorpions
(Arthropoda), and snakes (Chordata) has been compensated by developing
venomous competence and predation based on ambush behavior. A mixture
of deadly toxins that act simultaneously on multiple sites of the
neuromuscular system and are capable of immobilizing a fast moving prey
is injected to the target animal by a special stinging device.
Extensive analysis of these toxins has shown that within a given animal
group, the battery of functionally diverse toxic polypeptides evolved
from a common ancestor (divergence evolution) (1
2
3
4
5
6)
.
However, recognition of similar target sites occurs in many instances
by genetically unrelated toxins whose bioactive site has been formed
independently (convergence evolutione.g., potassium channel blockers
such as
-dendrotoxins from the green mamba snake Dendroaspis
angusticeps; charybdotoxin from the scorpion Leiurus
quinquestriatus hebraeus; BgK sea anemone toxin from
Bunodosoma granulifera; PVIIA
-conotoxin from Conus
purpurascens) (reviewed in ref 6
).
Divergent evolution of bioactive sites on conserved protein
scaffolds has been shown for snake toxins, such as curarimimetics and
fasciculins, that share a three-fingered fold but act on distinct
targets in the neuromuscular junction (nicotinic acetyl choline
receptors or acetylcholine esterases, respectively; reviewed in ref
5
). Similarly, snake dendrotoxins and bovine pancreatic
trypsin inhibitors, which share a similar scaffold composed of two
short helices and a two-stranded ß-sheet, target either various
potassium channels or the active site of proteases, respectively
(7
8
9)
. In these examples, the bioactive sites are located
at topographically unrelated regions of the conserved protein
scaffolds. An alternative route of divergence has been adopted by cone
snails that produce a large variety of small peptides (conotoxins),
which are typified by a structural motif termed cystine knot
(10)
and by their ability to block various types of ion
channels. Diversification of conotoxins has been achieved via gene
duplication, accelerated mutagenesis, insertion of unusual amino acid
residues, and various posttranslational modifications, thereby
generating a large number of variants with high specificity to various
ion channel subtypes (2
, 11)
. A unique route of
diversification of bioactive sites has recently emerged from studies of
scorpion toxins that produce different pharmacological effects on
binding to neuronal sodium channels (12
13
14
15)
.
SCORPION NEUROTOXINS AFFECTING SODIUM CHANNELS
Scorpions, whose senses are undeveloped, have survived more than
350 million years with no detectable changes in their anatomy due to
their efficient, dynamic machinery for the production and
diversification of neurotoxins. They produce a wide array of
structurally conserved toxic polypeptides capable of poisoning animals
of vast phylogenetic origin (16)
. In particular, toxins
affecting voltage-gated sodium channels exert the utmost impact on both
vertebrates and invertebrates (15
, 16)
. Despite general
conservation in channel structure and function, these toxins exhibit
diverse binding properties to sodium channels in various excitable
tissues, indicating differences in receptor sites (15)
.
The ever-changing receptor sites along evolution required structural
reshaping of the toxic ligands, a task fulfilled successfully by
scorpions of the family Buthidae. The conservation of toxin
3-dimensional structure (3-D) (15
, 17)
alongside an
inevitable demand for diverse bioactive sites has posed competing
pressures on the evolution of these polypeptides.
Diverse pharmacology
Scorpion toxins affecting sodium channels are 6176 amino
acid-long polypeptides that have been divided into two major classes,
and ß, according to their mode of action and binding properties
(15
, 16)
. These two classes induce different modulation of
the sodium current by binding at two distinct receptor sites on the
sodium channels.
-Toxins inhibit inactivation of the sodium current
by binding to receptor site 3 and are subdivided into distinct
pharmacological groups according to their preference for
phylogenetically distinct target sites (12
, 15)
.
Conversely, ß-toxins shift the activation of the sodium current to a
more negative membrane potential by binding to receptor site 4
(12
, 13)
. Most
- and ß-toxins affect mammalian and
insect sodium channels with various affinities. However, two
pharmacologically distinct toxin groups, excitatory and depressant,
which affect exclusively sodium channels of insects, have been
characterized (18
, 20)
. Both groups induce opposite
effects on the sodium current by affecting the activation process of
the sodium channel (18
, 20)
and bind to distinct yet
closely related receptor sites (21)
. For these reasons and
due to their capability to compete with ß-toxins for the receptor
binding site, excitatory and depressant toxins have been suggested to
belong to the ß class (15)
. Sequence comparison among
the various groups reveals
30% similarity, whereas the toxins
within each group may differ up to 50% (15
, 17
;
Fig. 1
).
|
Conservation of 3-D structure
The 3-D structure of several
-toxins has been known for more
than a decade (15
, 17
, 22)
, but it is only recently that
the structure of an anti-insect selective excitatory toxin
(23)
and that of an anti-mammalian ß-toxin
(24)
have been solved. In addition, the resemblance
between depressant and ß-toxins in sequence, neurophysiological
action, and competition for receptor binding site (15)
permits structural modeling of depressant toxins. Despite their diverse
bioactivity and sequence, all the above toxins share a common scaffold
comprising a
-helix and a three-stranded anti-parallel ß-sheet
(
/ß scaffold) that occupies most of their globular structure. The
/ß scaffold is stabilized by three spatially conserved disulfide
bridges and a fourth bridge is conserved in all but the excitatory
toxins (23
, 25)
(Fig. 1)
. Moreover, all these toxins
contain a solvent-exposed patch of aromatic and hydrophobic residues,
coined conserved hydrophobic surface, whose function is still
unknown. The mutual disposition of the
-helix and the ß-sheet in
all toxins is similar. However, the carboxy-terminal stretch and the
regions connecting the secondary structure elements differ in the
various toxins (15)
.
Similarity in genomic organization
Recently, the similar genomic organization of all the
aforementioned toxin genes has been shown. All genes contain A+T-rich
introns that split, at a conserved location, an amino acid codon of the
signal sequence. The introns vary in length and sequence, but display
identical boundaries and contain T runs downstream of a putative
conserved branch point (3)
.
Hence, on the basis of three levels of comparison (function,
structure, and gene organization), it has been suggested that all
scorpion neurotoxins affecting sodium channels have diverged from a
common ancestor (3
, 4)
. Nonetheless, all descendants show
vast sequence diversity, reflecting a high degree of inherent
permissiveness to amino acid substitutions without detrimental
deformation of the overall fold. To envisage a mechanism by which novel
bioactive sites have evolved, a comparison of toxin structures and
bioactive surfaces is required.
IDENTIFICATION OF BIOACTIVE SURFACES AND STRUCTURE COMPARISON
An efficient system for production of recombinant toxins in
milligram amounts (20
, 26
, 27)
has enabled structure
determination (23
, 28)
and genetic dissection (20
, 29)
of two toxins that represent distinct pharmacological
classes: Lqh
IT from the
class and Bj-xtrIT from the ß class.
Seven residues organized in a belt shape surrounding the toxin molecule
are important for bioactivity of Lqh
IT as their substitution reduced
toxicity at least fivefold compared to the unmodified toxin
(29
and Fig. 2
). Three of themArg58, Val59, and Lys62belong to the C-tail; the
side chains of the rest (Lys8, Tyr10, Phe17, and Arg18) are located on
the outer surface of the
/ß scaffold (Fig. 2
, bottom right). In
the excitatory toxin Bj-xtrIT, substitution of Asp55, Asp70, Ser76,
Asn28, and Tyr36 reduced toxicity more than fivefold whereas
substitution of Ile73 and Ile74 had a much larger effect of 100-fold
(20
and Fig. 2
, bottom left). These analyses highlight
residues important for bioactivity that are contributed by the C-tail
as well as by the surface vicinal to its disulfide anchoring site on
the molecule exterior.
|
Superposition of the C
backbones of the
-toxin Lqh
IT
(28)
, ß-toxin Cn2 (24)
, and excitatory
toxin Bj-xtrIT (23)
highlight the 180° positional shift
of the C-tail of Bj-xtrIT and its fourth disulfide bridge relative to
the other toxins (Figs. 1
and 2)
. The orientation of the bioactive
surface with respect to the
/ß scaffold differs between Bj-xtrIT
and Lqh
IT and seems to correspond to the molecular exterior onto
which the C-tail is anchored. To verify this hypothesis, we analyzed
LqhIT2, a toxin representative of the depressant group that, unlike the
excitatory and
-toxins, decreases the sodium current in cockroach
neuronal membranes (15
, 19)
. Mutagenesis of Asn58 and
Gly61 of the C-tail, as well as Asp8, Lys11, Lys26 of its vicinal
surface, reduced the toxicity of LqhIT2 more than fivefold (Fig. 2
and
unpublished results). These residues form a bioactive surface
encompassing the fourth disulfide bridge that anchors the C-tail onto
the molecule (Fig. 2
, bottom center).
From these analyses, it has become evident that the bioactive surface of each toxin examined thus far includes the distal region of the C-tail and spatially vicinal residues. Furthermore, substitution of the residues contributed by the distal part of the C-tail had the utmost effect on bioactivity.
A comparison of the structural models of Lqh
IT, Cn2, Bj-xtrIT, and
LqhIT2 accentuates the difference in the spatial arrangement of the
C-tail (23
, 24
, 28)
(Fig. 2)
. As implicated from several
toxin solution structures, the carboxy-terminal region is dynamic
despite its anchoring onto the polypeptide scaffold by the fourth
disulfide bridge (17
, 28
, 30
, 31)
. In contrast to the
spatial conservation of this bridge in
-, ß-, and depressant
toxins, its position in excitatory toxins is different (23
, 25)
(Fig. 1)
but with no structural perturbation of the
conserved
/ß scaffold (23
and Fig. 2
). Superposition
of the four toxins explicitly indicates a common start point after the
third ß-strand, from which all C-tails diverged (Fig. 2)
. Hence, all
toxins constitute on the one hand a rigid
/ß scaffold and, on the
other hand, a highly variable carboxy-terminal tail confined mainly by
the fourth disulfide bridge (Fig. 2)
.
DIVERSIFICATION OF BIOACTIVE SURFACES
These observations illuminate a putative evolutionary route for
diversification of bioactive surfaces possibly in an accelerated
manner. In this scenario, the carboxy-terminal region, starting after
the third ß-strand and protruding out of the
/ß scaffold, has
undergone structural rearrangements as a result of amino acid
substitutions that led to the formation of new molecular exteriors. The
evolutionary wiggling of the C-tail has been confined by the fourth
disulfide bridge, whose position in excitatory toxins is remote from
the conserved position in all other toxins (Fig. 2)
. The shift in
position in excitatory toxins has most likely occurred in parallel to
the insertion of an additional
-helical module (23)
serving presumably as a molecular lever facilitating the structural
alteration. Thus, we hypothesize that alterations in a short
hypervariable region, having a limited degree of structural freedom due
to the fourth disulfide bridge, induced the formation of a variety of
bioactive surfaces. This process may have occurred in parallel to the
evolutionary changes of target sites in sodium channels. The molecular
surfaces exerting novel bioactivities with an advantage for predation
or defense have most likely become the progenitors of the existing
pharmacological groups, e.g., alpha and its subgroups, beta,
excitatory, and depressant toxins. Apparently, additional alterations
of residues in these surfaces enabled increase in binding affinity to
the various receptor sites. The vast genetic polymorphism of all
scorpion neurotoxins (3)
suggests that the evolutionary
process has not ceased and that the pharmaceutical factory in
scorpion venom glands still seeks new bioactive sites.
From a mechanistic point of view, this scorpion toxin model is
reminiscent of the diversification of antigen binding sites that occurs
in the immune system. The variable light and heavy chains of antibodies
constitute two domains, a hypervariable unit comprising six
complementarity-determining regions (CDRs) and a framework region
exhibiting fewer variations. The framework region serves as a scaffold
for structural disposition of the CDR loops of the heavy and the light
chains. Superposition of all antibody structures reveals differences in
CDR loop orientation, length, and amino acid composition, thereby
generating a wide spectrum of specificities (32)
.
Although scorpion toxins and antibodies are by no means comparable, it is interesting to observe a strategic commonality in their diversification where only a section of the protein displays structural variability, thereby inducing changes in an interactive molecular face to cope with ever-changing targets at minimal energy expense.
In summary, comparative analysis of the structure, bioactive
surface, and pharmacology of scorpion toxins affecting sodium channels
sheds a new light on a putative evolutionary mechanism of bioactive
site formation. It may further aid in the prediction of unknown toxic
surfaces concentrating on the molecular surface around the C-tail
anchoring site and perhaps facilitate the design of novel effectors of
sodium channels using the highly conserved skeleton of scorpion toxins
(33)
.
ACKNOWLEDGMENTS
Our research was supported by grants IS-290197C from BARD, The United States-Israel Binational Agricultural Research & Development; 466/97 from The Israel Academy of Sciences and Humanities; 131-1037-98 from DIARP, a Joint Dutch-Israeli Agricultural Research Program; and a fund from the Biotechnology Infrastructure Program of the Israeli Ministry of Science, 1998.
REFERENCES
-dendrotoxin: the functional topographies of dendrotoxins are different but share a conserved core with those of other Kv1 potassium channel blocking toxins. J. Biol. Chem. 273,25393-25403
-like toxin that is active on insects and mammals reveals an unexpected specificity and distribution of sodium channel subtypes in rat brain neurons. J. Neurosci. 19,8730-8739
-helix at the C-terminus and its implications for interaction with insect sodium channels. Structure 6,1095-1103[Medline]
-toxin and a mutant with increased activity. Biochemistry 36,2414-2424[Medline]
-neurotoxin affecting voltage-sensitive sodium channels. J. Biol. Chem. 272,14810-14816
-like toxin from the scorpion Leiurus quinquestriatus hebraeus. J. Mol. Biol. 285,1749-1763[Medline]
This article has been cited by other articles:
![]() |
L. Cohen, N. Lipstein, I. Karbat, N. Ilan, N. Gilles, R. Kahn, D. Gordon, and M. Gurevitz Miniaturization of Scorpion {beta}-Toxins Uncovers a Putative Ancestral Surface of Interaction with Voltage-gated Sodium Channels J. Biol. Chem., May 30, 2008; 283(22): 15169 - 15176. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cohen, N. Lipstein, and D. Gordon Allosteric interactions between scorpion toxin receptor sites on voltage-gated Na channels imply a novel role for weakly active components in arthropod venom FASEB J, September 1, 2006; 20(11): 1933 - 1935. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cohen, N. Gilles, I. Karbat, N. Ilan, D. Gordon, and M. Gurevitz Direct Evidence That Receptor Site-4 of Sodium Channel Gating Modifiers Is Not Dipped in the Phospholipid Bilayer of Neuronal Membranes J. Biol. Chem., July 28, 2006; 281(30): 20673 - 20679. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cohen, I. Karbat, N. Gilles, N. Ilan, M. Benveniste, D. Gordon, and M. Gurevitz Common Features in the Functional Surface of Scorpion {beta}-Toxins and Elements That Confer Specificity for Insect and Mammalian Voltage-gated Sodium Channels J. Biol. Chem., February 11, 2005; 280(6): 5045 - 5053. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Karbat, F. Frolow, O. Froy, N. Gilles, L. Cohen, M. Turkov, D. Gordon, and M. Gurevitz Molecular Basis of the High Insecticidal Potency of Scorpion {alpha}-Toxins J. Biol. Chem., July 23, 2004; 279(30): 31679 - 31686. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. IZHAR, C. LIOR, G. NICOLAS, G. DALIA, and G. MICHAEL Conversion of a scorpion toxin agonist into an antagonist highlights an acidic residue involved in voltage sensor trapping during activation of neuronal Na+ channels FASEB J, April 1, 2004; 18(6): 683 - 689. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cohen, I. Karbat, N. Gilles, O. Froy, G. Corzo, R. Angelovici, D. Gordon, and M. Gurevitz Dissection of the Functional Surface of an Anti-insect Excitatory Toxin Illuminates a Putative "Hot Spot" Common to All Scorpion {beta}-Toxins Affecting Na+ Channels J. Biol. Chem., February 27, 2004; 279(9): 8206 - 8211. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |